Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 8/20 | 0.39 |
| ▸ | LMNA | P02545 | 4/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 6/20 | 0.36 |
| ▸ | CXCR1 | P25024 | 4/20 | 0.36 |
| ▸ | CXCR2 | P25025 | 4/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.36 |
| ▸ | CXCL8 | P10145 | 2/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 2/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.36 |
| ▸ | ALB | P02768 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | NR1I3 | Q14994 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17765333 | 0.83 | LMNA (0.36) | LMNAAKR1C3AKR1C2 | |
| SCHEMBL11679493 | 0.82 | PTGS2 (0.47) | PTGS2LMNAPTGS1AKR1C3CYP2C9 | |
| SCHEMBL6037597 | 0.81 | LMNA (0.51) | LMNAAKR1C3AKR1C2TSHRSMN1; SMN2 | |
| SCHEMBL11678400 | 0.79 | KMO (0.39) | PTGS2PTGS1SMN1; SMN2KDM4EHIF1A | |
| SCHEMBL10484478 | 0.79 | LMNA (0.50) | LMNAAKR1C3AKR1C2TSHRSMN1; SMN2 | |
| SCHEMBL31240136 | 0.79 | MAPT (0.43) | PTGS2AKR1C3AKR1C2SMN1; SMN2MAPT | |
| SCHEMBL11678265 | 0.78 | ACACB (0.41) | PTGS2LMNATP53SMN1; SMN2MAPT | |
| SCHEMBL11684120 | 0.78 | KMO (0.41) | SMN1; SMN2KDM4EHIF1A | |
| SCHEMBL31425044 | 0.78 | KDM4E (0.48) | PTGS2TSHRTP53SMN1; SMN2RXFP1 | |
| SCHEMBL18982637 | 0.78 | KDM4E (0.48) | PTGS2TSHRTP53SMN1; SMN2RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117630189-A | Method for detecting hexyl aminolevulinate hydrochloride | 广东精观生物医药科技有限公司 | 2024-03-01 | — | — | CN | disclosed |
| CN-101472879-B | Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof | COSMO OIL CO LTD | 2013-11-13 | — | — | CN | disclosed |
| CN-101472879-A | Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof | COSMO OIL CO LTD (JP) | 2009-07-01 | — | — | CN | disclosed |
| EP-2007711-A1 | 5-AMINOLEVULINIC ACID SALTS AND THEIR USE | Bar Ilan University (IL) | 2008-12-31 | — | — | EP | disclosed |
| US-20070225518-A1 | 5-Aminolevulinic acid salts and their use | SYNERON MEDICAL LTD. (IL) | 2007-09-27 | — | — | US | disclosed |
| WO-2007107998-A1 | 5-AMINOLEVULINIC ACID SALTS AND THEIR USE | BAR ILAN UNIVERSITY (IL) | 2007-09-27 | — | — | WO | disclosed |
| EP-1007504-B1 | STERILIZED 5-AMINOLEVULINIC ACID | DUSA PHARMACEUTICALS INC (CA) | 2004-06-09 | — | — | EP | disclosed |
| US-6335465-B1 | COLORED 5-AMINOLEVULINIC ACID CRYSTALS, WHEREIN SAID COLOR IS IMPARTED BY IRRADIATION OF CRYSTALS | DUSA PHARMACEUTICALS, INC. (CA) | 2002-01-01 | — | — | US | disclosed |
| EP-1007504-A1 | STERILIZED 5-AMINOLEVULINIC ACID | Dusa Pharmaceuticals, Inc. (CA) | 2000-06-14 | — | — | EP | disclosed |
| WO-1999011604-A9 | STERILIZED 5-AMINOLEVULINIC ACID | DUSA PHARMACEUTICALS INC (CA) | 1999-07-08 | — | — | WO | disclosed |
| WO-1999011604-A1 | STERILIZED 5-AMINOLEVULINIC ACID | DUSA PHARMACEUTICALS, INC. (CA) | 1999-03-11 | — | — | WO | disclosed |
| US-5856566-A | COLORED PARTICLES; IRRADIATION OF CRYSTALS | DUSA PHARMACEUTICALS, INC. (CA) | 1999-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225518-A1 | 5-Aminolevulinic acid salts and their use | ALAD, ALOX5, ADSL | PTGS2 659/4885LMNA 3784/4885PTGS1 1325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.